Biosante Pharmaceuticals (BPAX)
|
1.35
+0.02 (+1.50%)
|
|
|
|
BPAX analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
BPAX price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
BPAX earnings
Date
Actual
Expected
Prev Yr Qtr
11/8/2012
-0.27
-0.30
-0.72
8/1/2012
-0.36
-0.41
-0.96
5/8/2012
-0.09
-0.06
-0.20
Biosante Pharmaceuticals (BPAX) Upgrades
Date
Analyst
Old Rating
New Rating
No upgrades listed for BPAX at this time.
Biosante Pharmaceuticals (BPAX) Downgrades
Date
Analyst
Old Rating
New Rating
No downgrades listed for BPAX at this time.
Biosante Pharmaceuticals (BPAX) New Coverage
Date
Analyst
Rating
10/13/2010
Roth Capital
Buy
11/09/2009
Rodman and Renshaw
Outperform
